Sector: MedicalLehman ABS Corporation (NYSE: BMY)
Ranking History
Scan Date: | 10/27/2009 |
Sector: | Medical |
Funamental : | 180 |
Technical : | 230 |
Performance : | 242 |
Overall: | 264 |
Number of Stocks: | 306 |
Scan Date: | 10/20/2009 |
Sector: | Medical |
Funamental : | 150 |
Technical : | 241 |
Performance : | 231 |
Overall: | 258 |
Number of Stocks: | 305 |
Scan Date: | 10/15/2009 |
Sector: | Medical |
Funamental : | 154 |
Technical : | 235 |
Performance : | 218 |
Overall: | 246 |
Number of Stocks: | 305 |
Headlines
- FDA Approves Labeling Update for REYATAZ(R) (atazanavir sulfate) Capsules to Include 96-Week Data for Previously Untreated HIV-1 Infected Adult Patients
Nov 05, 2009 06:09 PM | BMY
- Repligen Reports Second Quarter Fiscal Year 2010 Financial Results
Nov 05, 2009 07:01 AM | BMY, RGEN
- Zyngenia, Inc. Raises $10 Million in Series A Funding
Nov 04, 2009 02:00 PM | BMY
- Thirteen Abstracts Featuring Exelixis Compounds Accepted for Presentation at the 2009 AACR-NCI-EORTC International Conference
Nov 04, 2009 06:00 AM | BMY, EXEL, SNY
- Phase Forward to Host Eighth Annual International Users Conference, November 3-5, Boston
Nov 02, 2009 09:01 AM | BMY, FOLD, GENZ, PFWD
- Third Compound from AMRI Bristol-Myers Squibb Collaboration Selected for Preclinical Development
Nov 02, 2009 08:00 AM | AMRI, BMY
- BARACLUDE(R) (entecavir) Demonstrated Greater Antiviral Efficacy Compared to Adefovir in New Study of Chronic Hepatitis B Patients with Evidence of Decompensated Cirrhosis
Oct 31, 2009 05:31 PM | BMY
- Bristol-Myers Squibb and ZymoGenetics Present Final Phase 1b Results for PEG-Interferon Lambda in Hepatitis C
Oct 31, 2009 05:30 PM | BMY, ZGEN
- Windhover Expands Its List of Top Projects to Watch
Oct 30, 2009 01:13 PM | AZN, BIIB, BMY, BVF, ENL, GENZ
- Mead Johnson Nutrition Announces Pricing of Notes Offering
Oct 30, 2009 08:51 AM | BMY
- Earnings Preview: Bristol-Myers 3Q earnings report
Oct 21, 2009 11:53 AM | AZN, BMY, GSK, JNJ, LLY, MRK
- Chicago Tribune Gail MarksJarvis Column: Recession's End Doesn't Make Stock Picking Easy
Sep 16, 2009 05:55 AM | BMY, INTC, MCD, WMT
- Daily Mail, London, Market Report Column
Sep 02, 2009 10:54 AM | AZ, AZN, BMY, SNY
- Evening Standard, London, Market Report Column
Sep 01, 2009 05:56 PM | AZ, AZN, BMY, C, GS, GSK
- UPI NewsTrack Business
Aug 01, 2009 11:37 AM | BMY, GOOG, HMC, T
- Onglyza approved for Type 2 Diabetes
Aug 01, 2009 11:31 AM | BMY
- Astra 2Q profit up 6 pct as it cuts costs
Jul 30, 2009 02:50 PM | AZN, BMY
- Home Sales, Earnings Reports Ignite Markets
Jul 24, 2009 11:01 AM | BMY, FRE, IHS, WYE
- Dow tops 9,000 as home sales rise for 3rd month
Jul 23, 2009 06:54 PM | AMZN, AXP, BMY, CAT, F, FII
- Strong sales boost Bristol-Myers 2Q profit
Jul 23, 2009 05:58 PM | BMY, LLY, MEDX
- Bristol-Myers Squibb Achieves Strong Sales, Earnings Performance in Third Quarter
Oct 22, 2009 07:51 AM | AZN, BMY, GILD, LLY
- Mead Johnson Reports Solid Third Quarter Results; Narrows Full-Year 2009 Guidance to Top End of Range
Oct 22, 2009 07:51 AM | BMY
- Bristol-Myers Squibb Announces Dividend
Sep 09, 2009 04:51 PM | BMY
- Bristol-Myers Squibb Completes Acquisition of Medarex, Inc.
Sep 01, 2009 05:56 PM | BMY, MEDX
- Bristol-Myers Squibb Completes Initial Tender Offer for Medarex, Inc. With 87.7% of Shares Tendered; Announces Subsequent Offering Period
Aug 27, 2009 09:55 AM | BMY, MEDX
- Bristol-Myers Squibb Extends Tender Offer for Medarex, Inc.
Aug 20, 2009 05:51 PM | BMY, MEDX
- Morning Watch for Wednesday: Sunwin International Neutraceuticals - August 19, 2009
Aug 19, 2009 09:56 AM | BMY, JNJ, MRX, SUWN
- StockPreacher.com issues Trading Outlook for Spectrum Pharmaceuticals Inc.
Aug 05, 2009 06:50 AM | AGN, BMY, JNJ, PRX, SPPI
- AMRI Announces Second Quarter 2009 Results
Aug 04, 2009 06:51 PM | AMRI, BMY
- ZymoGenetics Reports Second Quarter 2009 Financial Results
Aug 03, 2009 04:51 PM | BMY, ZGEN
- Form 4 MCBRIDE ANTHONY A For: Nov 01 (10K)
Nov 02, 2009 05:03 PM
- Form 4 Williams R Sanders For: Sep 30 (10K)
Oct 02, 2009 03:08 PM
- Form 4 WEST TOGO D JR For: Sep 30 (10K)
Oct 02, 2009 03:08 PM
- Form 4 GROBSTEIN MICHAEL For: Sep 30 (10K)
Oct 02, 2009 03:08 PM
- Form 4 HOOPER ANTHONY C For: Sep 21 (10K)
Sep 22, 2009 03:32 PM
- Form 4 SIGAL ELLIOT For: Sep 21 (10K)
Sep 22, 2009 03:32 PM
- Form 4 ANDREOTTI LAMBERTO For: Sep 21 (10K)
Sep 22, 2009 03:32 PM
- Form 4 Zito Robert T For: Aug 02 (10K)
Aug 04, 2009 06:05 PM
- Form 4 WEST TOGO D JR For: Jun 30 (10K)
Jul 02, 2009 05:48 PM
- Form 4 GROBSTEIN MICHAEL For: Jun 30 (10K)
Jul 02, 2009 05:48 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
BMY
|
Compare to S&P
|
| YTD |
-6.24 %
|
-18.27 %
|
| 4 Weeks |
-2.07 %
|
-3.10 %
|
| 12 Weeks |
-0.46 %
|
-2.93 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -7.14 %
|
|
EPS Growth in Last Year: 13.04 %
|
|
Sales Growth in Last Quarter: 1.91 %
|
|
Sales Growth in Last Quarter: 4.43 %
|
|
